183 related articles for article (PubMed ID: 26686248)
21. [CALM-AF10 fusion transcripts in primary leukemia with t(10;11) and in vitro chemotherapy sensitivity of leukemic cells with t(10;11)].
Ou DM; Liu GX; Yan JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):770-3. PubMed ID: 15631658
[TBL] [Abstract][Full Text] [Related]
22. Alternative splicing in wild-type AF10 and CALM cDNAs and in AF10-CALM and CALM-AF10 fusion cDNAs produced by the t(10;11)(p13-14;q14-q21) suggests a potential role for truncated AF10 polypeptides.
Silliman CC; McGavran L; Wei Q; Miller LA; Li S; Hunger SP
Leukemia; 1998 Sep; 12(9):1404-10. PubMed ID: 9737689
[TBL] [Abstract][Full Text] [Related]
23. Mixed-lineage leukemia with t(10;11)(p13;q21): an analysis of AF10-CALM and CALM-AF10 fusion mRNAs and clinical features.
Kumon K; Kobayashi H; Maseki N; Sakashita A; Sakurai M; Tanizawa A; Imashuku S; Kaneko Y
Genes Chromosomes Cancer; 1999 May; 25(1):33-9. PubMed ID: 10221337
[TBL] [Abstract][Full Text] [Related]
24. The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in mice.
Deshpande AJ; Rouhi A; Lin Y; Stadler C; Greif PA; Arseni N; Opatz S; Quintanilla-Fend L; Holzmann K; Hiddemann W; Döhner K; Döhner H; Xu G; Armstrong SA; Bohlander SK; Buske C
Leukemia; 2011 Nov; 25(11):1718-27. PubMed ID: 21681188
[TBL] [Abstract][Full Text] [Related]
25. Lymphoid progenitors as candidate cancer stem cells in AML: new perspectives.
Deshpande AJ; Buske C
Cell Cycle; 2007 Mar; 6(5):543-5. PubMed ID: 17329976
[TBL] [Abstract][Full Text] [Related]
26. Nuclear export signal within CALM is necessary for CALM-AF10-induced leukemia.
Suzuki M; Yamagata K; Shino M; Aikawa Y; Akashi K; Watanabe T; Kitabayashi I
Cancer Sci; 2014 Mar; 105(3):315-23. PubMed ID: 24397609
[TBL] [Abstract][Full Text] [Related]
27. The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest.
Ben Abdelali R; Asnafi V; Petit A; Micol JB; Callens C; Villarese P; Delabesse E; Reman O; Lepretre S; Cahn JY; Guillerm G; Berthon C; Gardin C; Corront B; Leguay T; Béné MC; Ifrah N; Leverger G; Dombret H; Macintyre E
Haematologica; 2013 Nov; 98(11):1711-7. PubMed ID: 23831922
[TBL] [Abstract][Full Text] [Related]
28. The role of CALM-AF10 gene fusion in acute leukemia.
Caudell D; Aplan PD
Leukemia; 2008 Apr; 22(4):678-85. PubMed ID: 18094714
[TBL] [Abstract][Full Text] [Related]
29. CALM/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12.
Mulaw MA; Krause A; Deshpande AJ; Krause LF; Rouhi A; La Starza R; Borkhardt A; Buske C; Mecucci C; Ludwig WD; Lottaz C; Bohlander SK
Leukemia; 2012 May; 26(5):1012-9. PubMed ID: 22064352
[TBL] [Abstract][Full Text] [Related]
30. Dual-color split signal fluorescence in situ hybridization assays for the detection of CALM/AF10 in t(10;11)(p13;q14-q21)-positive acute leukemia.
La Starza R; Crescenzi B; Krause A; Pierini V; Specchia G; Bardi A; Nieddu R; Ariola C; Nanni M; Diverio D; Aventin A; Sborgia M; Martelli MF; Bohlander SK; Mecucci C
Haematologica; 2006 Sep; 91(9):1248-51. PubMed ID: 16956826
[TBL] [Abstract][Full Text] [Related]
31. Effects of iron depletion on CALM-AF10 leukemias.
Heath JL; Weiss JM; Lavau CP; Wechsler DS
Exp Hematol; 2014 Dec; 42(12):1022-1030.e1. PubMed ID: 25193880
[TBL] [Abstract][Full Text] [Related]
32. Global reduction of the epigenetic H3K79 methylation mark and increased chromosomal instability in CALM-AF10-positive leukemias.
Lin YH; Kakadia PM; Chen Y; Li YQ; Deshpande AJ; Buske C; Zhang KL; Zhang Y; Xu GL; Bohlander SK
Blood; 2009 Jul; 114(3):651-8. PubMed ID: 19443658
[TBL] [Abstract][Full Text] [Related]
33. MOZ/ENL complex is a recruiting factor of leukemic AF10 fusion proteins.
Komata Y; Kanai A; Maeda T; Inaba T; Yokoyama A
Nat Commun; 2023 Apr; 14(1):1979. PubMed ID: 37031220
[TBL] [Abstract][Full Text] [Related]
34. Unexpected variation in leukemia stem cell frequency and genetic heterogeneity in two murine leukemia models initiated by AML1/ETO9a and CALM/AF10.
Desai R; Taghavi S; Chase JC; Chopra M; Chien J; Browett PJ; Kakadia PM; Bohlander SK
Leukemia; 2020 Jun; 34(6):1706-1710. PubMed ID: 31801964
[No Abstract] [Full Text] [Related]
35. The role of the PZP domain of AF10 in acute leukemia driven by AF10 translocations.
Klein BJ; Deshpande A; Cox KL; Xuan F; Zandian M; Barbosa K; Khanal S; Tong Q; Zhang Y; Zhang P; Sinha A; Bohlander SK; Shi X; Wen H; Poirier MG; Deshpande AJ; Kutateladze TG
Nat Commun; 2021 Jul; 12(1):4130. PubMed ID: 34226546
[TBL] [Abstract][Full Text] [Related]
36. Leukemogenic potency of the novel FLT3-N676K mutant.
Huang K; Yang M; Pan Z; Heidel FH; Scherr M; Eder M; Fischer T; Büsche G; Welte K; von Neuhoff N; Ganser A; Li Z
Ann Hematol; 2016 Apr; 95(5):783-91. PubMed ID: 26891877
[TBL] [Abstract][Full Text] [Related]
37. The CALM and CALM/AF10 interactor CATS is a marker for proliferation.
Archangelo LF; Greif PA; Hölzel M; Harasim T; Kremmer E; Przemeck GK; Eick D; Deshpande AJ; Buske C; de Angelis MH; Saad ST; Bohlander SK
Mol Oncol; 2008 Dec; 2(4):356-67. PubMed ID: 19383357
[TBL] [Abstract][Full Text] [Related]
38. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?
Muntean AG; Hess JL
Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728
[TBL] [Abstract][Full Text] [Related]
39. FHL2 interacts with CALM and is highly expressed in acute erythroid leukemia.
Pašaliç Z; Greif PA; Jurinoviç V; Mulaw M; Kakadia PM; Tizazu B; Fröhlich-Archangelo L; Krause A; Bohlander SK
Blood Cancer J; 2011 Nov; 1(11):e42. PubMed ID: 22829078
[TBL] [Abstract][Full Text] [Related]
40. CALM-AF10 fusion gene in leukemias: simple and inversion-associated translocation (10;11).
Salmon-Nguyen F; Busson M; Daniel M; Leblanc T; Bernard OA; Berger R
Cancer Genet Cytogenet; 2000 Oct; 122(2):137-40. PubMed ID: 11106826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
